Clinical trial
Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic
NCT02128919 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic
- Lead sponsor
- Nathan Kline Institute for Psychiatric Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- December 31, 2016
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cigarette smoking, cognition, schizophrenia